William D. Chey, MD, from Michigan Medicine, highlights the 3 phases of a low FODMAP diet in the treatment of IBS and the importance of moving a patient from the elimination phase to the reintroduction phase.

Cherise Rohr-Allegrini, PhD, MPH, discusses a timeline of vaccinations, what opting out of these vaccines means for the future of outbreaks, and what the public should learn from these outbreaks. For more content, visit https://www.consultant360.com/infectious-diseases.

Children with autism are more likely to have epilepsy, and vice versa. Madeline Fields, MD, from Mount Sinai Hospital, answers our questions about this connection.

Valeria C. Cohran, MD, from Ann & Robert H. Lurie Children’s Hospital of Chicago, discusses the current state of pediatric intestinal rehabilitation programs, treatment advances led by these programs, and more.

Joseph Diamond, MD, from the Icahn School of Medicine, answers the question at the end of Case #3 and discusses the difference between at-home vs in-lab polysomnography testing for sleep disordered breathing. Case part 3 here:

In part 2 of our series on lipid management, Dr Paul Jellinger explains the answer to the quiz question from part 1, the AACE lipid guidelines, and the role of renal disease in managing this patient. Part 1 here: https://www.consultant360.com/exclusive/cardiology/lipid-metabolic/what-older-mans-ldl-c-goal.

Jacob Miguel Vigil, PhD, discusses new study findings that suggest THC may confer more therapeutic benefit than CBD across many different health conditions, and why he says now is the “Golden Age” of cannabis research. For more, visit www.consultant360.com.

James Matera, DO, from CentraState Medical Center in New Jersey, discusses how lipid disorders impact the management of chronic kidney disease (CKD), and whether statins are safe for use in patients with comorbid lipid disorders and CKD. For more, visit www.consultant360.com.

David Malebranche, MD, MPH, talks about his session from the 2019 National HIV Prevention Conference, titled "We Are Family: Helping Patients Navigate the HIV Care Continuum." He discusses the current HIV care continuum, the knowledge gaps that still exist, and the art and science of medicine in HIV care. Read more: https://www.consultant360.com/specialty/infectious-diseases/hivaids.

Deepak Kaushal, PhD, from Texas Biomedical Research Institute, talks about new treatments for HIV, how they will change the way we treat HIV, and other medications for HIV on the horizon. More athttps://www.consultant360.com/specialty/infectious-diseases/hivaids.